Treatment of tularemia with fluoroquinolones: Two cases and review

被引:71
作者
Limaye, AP
Hooper, CJ
机构
[1] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA
关键词
D O I
10.1086/520458
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Streptomycin, gentamicin, and tetracycline are currently considered the antimicrobials of choice for the treatment of tularemia, Preliminary data suggest that quinolones may be effective alternative agents; however, clinical experience is limited, and their role in treating severe disease is uncertain. We recently treated two acutely ill immunocompromised patients who had presumed "atypical" pneumonia with levofloxacin, Both patients had an excellent clinical response and were diagnosed with tularemia only when blood cultures subsequently yielded Francisella tularensis. Neither patient relapsed during 12 months of follow-up. Including our two cases, a total of 10 cases of tularemia treated with quinolones have been reported. In all 10 cases, a favorable clinical response was documented, and no relapses occurred. We conclude that the quinolones appear promising for the treatment of even severe tularemia, and they should be considered efficacious alternative agents for patients who do not require parenteral therapy or are intolerant of more standard treatment regimens.
引用
收藏
页码:922 / 924
页数:3
相关论文
共 11 条
[1]
STREPTOMYCIN AND ALTERNATIVE AGENTS FOR THE TREATMENT OF TULAREMIA - REVIEW OF THE LITERATURE [J].
ENDERLIN, G ;
MORALES, L ;
JACOBS, RF ;
CROSS, JT .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (01) :42-47
[2]
Typhoidal tularemia in a human immunodeficiency virus-infected adolescent [J].
Gries, DM ;
Fairchok, MP .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (09) :838-840
[3]
WATERBORNE AND AIRBORNE FRANCISELLA-TULARENSIS BIOVAR PALAEARCTICA ISOLATED FROM HUMAN BLOOD [J].
HOEL, T ;
SCHEEL, O ;
NORDAHL, SHG ;
SANDVIK, T .
INFECTION, 1991, 19 (05) :348-350
[4]
Pneumonic tularemia in a patient with chronic granulomatous disease [J].
Maranan, MC ;
Schiff, D ;
Johnson, DC ;
Abrahams, C ;
Wylam, M ;
Gerber, SI .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :630-633
[5]
Parssinen O, 1997, ACTA OPHTHALMOL SCAN, V75, P732
[6]
PENN RL, 1995, MANDELL DOUGLAS BENN, P2060
[7]
ISOLATION OF FRANCISELLA-TULARENSIS FROM BLOOD [J].
PROVENZA, JM ;
KLOTZ, SA ;
PENN, RL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (03) :453-455
[8]
RELAPSE OF TULAREMIA AFTER AMINOGLYCOSIDE THERAPY - CASE-REPORT AND DISCUSSION OF THERAPEUTIC OPTIONS [J].
RISI, GF ;
POMBO, DJ .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) :174-175
[9]
The efficacy of ciprofloxacin and doxycycline against experimental tularaemia [J].
Russell, P ;
Eley, SM ;
Fulop, MJ ;
Bell, DL ;
Titball, RW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (04) :461-465
[10]
SUSCEPTIBILITY PATTERN OF SCANDINAVIAN FRANCISELLA-TULARENSIS ISOLATES WITH REGARD TO ORAL AND PARENTERAL ANTIMICROBIAL AGENTS [J].
SCHEEL, O ;
HOEL, T ;
SANDVIK, T ;
BERDAL, BP .
APMIS, 1993, 101 (01) :33-36